CAL
CRL icon

Capital Advisors Ltd’s Charles River Laboratories CRL Stock Holding History

Capital Advisors Ltd’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed – – 1402
2026
Q1 		$0 Buy
+1
New +$185 ﹤0.01% 1407
2025
Q1 		– Sell
-4
Closed -$1K – 1385
2024
Q4 		$1K Buy
4
+3
+300% +$578 ﹤0.01% 1169
2024
Q3 		$0 Hold
1
– – ﹤0.01% 1416
2024
Q2 		$0 Sell
1
-2
-67% -$453 ﹤0.01% 1424
2024
Q1 		$1K Buy
3
+2
+200% +$478 ﹤0.01% 1155
2023
Q4 		$0 Sell
1
-3
-75% -$590 ﹤0.01% 1324
2023
Q3 		$1K Sell
4
-1
-20% -$205 ﹤0.01% 1102
2023
Q2 		$1K Buy
+5
New +$995 ﹤0.01% 1113
2023
Q1 		– Sell
-2
Closed – – 1255
2022
Q4 		$0 Sell
2
-18
-90% -$3.93K ﹤0.01% 1284
2022
Q3 		$4K Buy
+20
New +$4.32K ﹤0.01% 666
2022
Q1 		– Sell
-1
Closed – – 948
2021
Q4 		$0 Buy
+1
New +$389 ﹤0.01% 832

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Capital Advisors Ltd's CRL Position: Q2 2026 in Review

Capital Advisors Ltd sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 1 share.

Capital Advisors Ltd first reported a position in CRL in Q4 2021 and held it in 11 quarters. The position peaked at $4K in Q3 2022. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Capital Advisors Ltd reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • Capital Advisors Ltd sold 1 Charles River Laboratories share in Q2 2026.
  • Capital Advisors Ltd first reported a position in Charles River Laboratories in Q4 2021 and held it in 11 quarters.
  • Capital Advisors Ltd's Charles River Laboratories position peaked at $4K in Q3 2022.
  • 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.